Skip to main content

Botulism immune globulin Pregnancy and Breastfeeding Warnings

Brand names: BabyBIG

Medically reviewed by Drugs.com. Last updated on Sep 18, 2023.

Botulism immune globulin Pregnancy Warnings

Animal studies have not been performed. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

This drug is not indicated for use in patients of childbearing age.

US FDA pregnancy category: Not assigned

Comments:
-This drug is only indicated for patients under 1 year old.

See references

Botulism immune globulin Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments:
-This drug is only indicated for patients under 1 year old.

See references

References for pregnancy information

  1. Product Information. BabyBIG (botulism immune globulin). FFF Enterprises. 2008.

References for breastfeeding information

  1. Product Information. BabyBIG (botulism immune globulin). FFF Enterprises. 2008.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.